REMD Biotherapeutics Announces Dosing of First Type 1 Diabetes Patient with REMD-477, a Glucagon Receptor Monoclonal Antibody Biotech Investing
American CryoStem Expands With New Stem Cell Processing and Cryogenic Storage Laboratory Biotech Investing
SeeThruEquity Initiates Coverage on Bion Environmental Technologies with a Price Target of $5.25 Agriculture Investing
Nerium Biotechnology Seeks Court-Ordered Termination of Business Venture with JO Products Biotech Investing
Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate Biotech Investing
Akari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With Coversin Biotech Investing
PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration Biotech Investing
European Medicines Agency Grants Accelerated Assessment of Marketing Authorization Application for Xilonix™, XBiotech’s True Human™ Therapeutic Antibody Treatment for Advanced Colorectal Cancer Biotech Investing
Lipoprotein(a) Foundation Highlights ACC Research Reinforcing the Significance of Lp(a) as a Genetic Risk Factor for Cardiovascular Disease Biotech Investing